Bacterial resistance to antibiotics has become an increasingly distressing problem over the last few decades. In this article, known resistance mechanisms are reviewed and the extent of the problem in both hospitals and nursing homes is addressed. Suggestions for preventing the further spread of this problem are presented.
Get full access to this article
View all access options for this article.
References
1.
DattaN, FaiersMC, ReevesDS, BrumfittW, OrskovF, OrskovI. R factors in Escherichia coli in faeces after oral chemotherapy in general practice.Lancet1971; 1: 312–7.
2.
HedgesR, JacobA. Transposition of ampicillin resistance from RP4 to other replicons.MGG1974; 132: 31–40.
3.
RichmondMH, SykesRB. The β-lactamases of gram-negative bacteria and their possible physiologic role.Adv Microb Physiol1973; 9: 31–88.
4.
NeuHC, FuKP. Clavulanic acid, a novel inhibitor of β-lactamases.Antimicrob Agents Chemother1978; 14: 650–5.
5.
SawaiT, MitsuhashiS, YamagishiS. Drug resistance of enteric bacteria. XIV. Comparison of β-lactamases in gram-negative rod bacteria resistant to α-aminobenzylpenicillin.Jap J Microbiol1968; 12: 423–34.
6.
AmblerRP. The structure of β-lactamases.Philos Trans R Soc Lond [Biol]1980; 289: 321–31.
7.
JaurinB, GrundstromT. ampC cephalosporinase of Escherichia coli K-12 has a different evolutionary origin from that of β-lactamases of the penicillinase type.Proc Natl Acad Sci USA1981; 78: 4897–901.
8.
BushK. Recent developments in β-lactamase research and their implications for the future.Rev Infect Dis1988; 10: 681–90.
9.
SandersCC, SandersWE. Emergence of resistance during therapy with the newer β-lactam antibiotics: role of inducible β-lactamases and implications for the future.Rev Infect Dis1983; 5: 639–48.
10.
ShannonK, PhillipsI. Mechanisms of resistance to aminoglycosides in clinical isolates.J Antimicrob Chemother1982; 9: 91–102.
11.
ShawWV. Chloramphenicol acetyltransferase from chloramphenicol-resistant bacteria.Meth Enzymol1975; 43: 737–55.
12.
BryanLE, HarphongeR, Van Den ElzenHM. Gentamicin resistance in clinical isolates of Pseudomonas aeruginosa associated with diminished gentamicin accumulation and no detectable enzymatic modification.J Antibiot1976; 29: 743–53.
13.
BryanLE, KowardSK, Van Den ElzenHM. Mechanisms of aminoglycoside antibiotic resistance in anaerobic bacteria: Clostridium perfringens and Bacteroides fragilis.Antimicrob Agents Chemother1979; 15: 7–13.
14.
GutmannL, WilliamsonR, MoreauN. Cross-resistance to nalidixic acid, trimethoprim, and chloramphenicol associated with alterations in outer membrane proteins of Klebsiella, Enterobacter, and Serratia.J Infect Dis1985; 151: 501–7.
15.
SawaiT, HirumaR, KawanaN, KanekoM, TaniyasuF, InamiA. Outer membrane permeation of β-lactam antibiotics in Escherichia coli, Proteus mirabilis, and Enterobacter cloacae.Antimicrob Agents Chemother1982; 22: 585–92.
16.
YamaguchiA, TomiyamaN, HirumaR, SawaiT. Difference in pathway of Escherichia coli outer membrane permeation between penicillins and cephalosporins.FEBS Lett1985; 181: 143–8.
17.
SawaiT, YamaguchiA, HirumaR. Effect of interaction between outer membrane permeability and β-lactamase production on resistance to β-lactam agents in gram-negative bacteria.Rev Infect Dis1988; 10: 761–4.
18.
HancockREW, WoodruffWA. Roles of porin and β-lactamase in β-lactam resistance of Pseudomonas aeruginosa.Rev Infect Dis1988; 10: 770–5.
19.
QuinnJP, StudemeisterAE, DivincenzoCA, LernerSA. Resistance to imipenem in Pseudomons aeruginosa: clinical experience and biochemical mechanisms.Rev Infect Dis1988; 10: 892–8.
20.
BallPR, ShalesSW, ChopraI. Plasmid mediated tetracycline resistance involves increased efflux of the antibiotic.Biochem Biophys Res Commun1980; 93: 74–81.
21.
NeuHC. Bacterial resistance to fluoroquinolones.Rev Infect Dis1988; 10(suppl l): S57–63.
22.
HackenbeckR, TarpayM, TomaszA. Multiple changes of penicillin-binding proteins in penicillin resistant clinical isolates of Streptococcus pneumoniae.Antimicrob Agents Chemother1980; 17: 364–8.
23.
RossiL, ToninE, ChengYR, FontanaR. Regulation of penicillin-binding protein activity: description of methicillin-inducible penicillin-binding protein in Staphylococcus aureus.Antimicrob Agents Chemother1985; 27: 828–31.
24.
WilliamsonR, LebouguenecG, GutmannL, HoraudT. One or two low affinity penicillin-binding proteins may be responsible for the range of susceptibility of Enterococcus faecium to benzylpenicillin.J Gen Microbiol1985; 131: 1933–40.
25.
DoughertyTJ, KoellerAD, TomaszA. Penicillin-binding proteins of penicillin susceptible and intrinsically resistant Neisseria gonorrhoeae.Antimicrob Agents Chemother1980; 18: 730–7.
26.
NeuHC. The biochemical basis of antimicrobial and bacterial resistance.Bull NY Acad Med1987; 63: 295–317.
27.
LaiCJ, WeisbaumB. Altered methylation of ribosomal RNA in an erythromycin-resistant strain of Staphylococcus aureus.Proc Natl Acad Sci USA1971; 68: 856–60.
28.
LaiCJ, WeisbaumB, FahrestockR, NomuraM. Alteration of 32S ribosomal RNA and erythromycin-induced resistance to lincomycin and spiramycin in Staphylococcus aureus.J Mol Biol1973; 74: 67–72.
29.
WehrliW. Rifampin: mechanisms of action and resistance.Rev Infect Dis1983; 5: 407–11.
30.
PatoML, BrownGM. Mechanisms of resistance of Escherichia coli to sulfonamides.Arch Biochem Biophys1963; 103: 443–8.
31.
AmyesSGB, SmithJT. R-factor trimethoprim resistance mechanism: an insusceptible target site.Biochem Biophys Res Commun1974; 58: 412–8.
32.
HaleyRW, CulverDH, WhiteJW, MorganWM, EmoriTG. The nationwide nosocomial infection rate: a new need for vital statistics.Am J Epidemiol1985; 121: 159–67.
33.
FinlandM. Changing patterns of susceptibility of common bacterial pathogens to antimicrobial agents.Ann Intern Med1972; 76: 1009–36.
34.
ThompsonRL, CabezudoI, WenzelRP. Epidemiology of nosocomial infections caused by methicillin-resistant Staphylococcus aureus.Ann Intern Med1982; 97: 309–17.
35.
WeinsteinRA, KabinsSA, NathanC, SweeneyHM, JaffeHW, CohenS. Gentamicin-resistant staphylococci as hospital flora: epidemiology and resistance plasmids.J Infect Dis1982; 145: 374–82.
36.
RubensCE, FarrarWEJr, McgeeZA. Evolution of a plasmid mediating resistance to multiple antimicrobial agents during a prolonged epidemic of nosocomial infections.J Infect Dis1981; 143: 170–81.
37.
BawdonRE, CraneLR, PalchaudhuriS. Antibiotic resistance in anaerobic bacteria: molecular biology and clinical aspects.Rev Infect Dis1982; 4: 1075–95.
38.
WeinsteinRA, KabinsSA. Strategies for prevention and control of multiple drug-resistant nosocomial infection.Am J Med1981; 70: 449–54.
39.
McgowanJEJr,. Antimicrobial resistance in hospital organisms and its relation to antibiotic use.Rev Infect Dis1983; 5: 1033–48.
40.
MaMY, GoldsteinEJC, FriedmanMH, AndersonMS, MulliganME. Resistance of gram-negative bacilli as related to hospital use of antimicrobial agents.Antimicrob Agents Chemother1983; 24: 347–52.
41.
PriceDJE, SleighJD. Control of infection due to Klebsiella aerogenes in a neurosurgical unit by withdrawal of all antibiotics.Lancet1970; 2: 1213–5.
42.
SogaardH, Zimmermann-NielsenC, SiboniK. Antibiotic-resistant gram-negative bacilli in a urological ward for male patients during a nine year period: relationship to antibiotic consumption.J Infect Dis1974; 130: 646–50.
43.
WeinsteinRA. Resistant bacteria and infection control in the nursing home and hospital.Bull NY Acad Med1987; 63: 337–44.
44.
GaribaldiRA, BodineS, MatsumiyaS. Infections among patients in nursing homes. Policies, prevalence, and problems.N Engl J Med1981; 305: 731–5.
45.
SmithPW. Consensus conference on nosocomial infections in long-term care facilities.Am J Infect Control1987; 15: 97–100.
46.
CrossleyK, HenryK, IrvineP, WillenbringK. Antibiotic use in nursing homes: prevalence, cost and utilization review.Bull NY Acad Med1987; 63: 510–8.
47.
GaynesRP, WeinsteinRA, ChamberlinW, KabinsSA. Antibiotic-resistant flora in nursing home patients admitted to the hospital.Arch Intern Med1985; 145: 1804–7.
48.
SandersWE, SandersCC. Inducible β-lactamases: clinical and epidemiologic implications for use of newer cephalosporins.Rev Infect Dis1988; 10: 830–8.
49.
MarrJJ, MoffetHL, KuninCM. Guidelines for improving the use of antimicrobial agents in hospitals: a statement by the Infectious Diseases Society of America.J Infect Dis1988; 157: 869–76.
50.
BarriereSL. Cost-containment of antimicrobial therapy.Drug Intell Clin Pharm1985; 19: 278–81.
51.
KuninCM. Problems of antibiotic usage. Definitions, causes and proposed solutions.Ann Intern Med1978; 89: 802–5.
